Our Mission

Having fulfilled the promise of its first decade by advancing the understanding of the potential of stem cell biology, HSCI is now focused on bringing stem cell-based treatments to patients as quickly as possible. While continuing to advance scientific discovery, we are developing treatments for diseases of aging, the blood, metabolism, and neurological disorders. To accomplish this, we bring together more than 1,000 scientists in the schools and affiliated hospitals of Harvard, fund novel research, and implement new collaborative academic and industrial models.

Learn What HSCI is Doing For Diseases in These Research Groups:

Public Events

2016 Oct 26

11th International BMP Conference

Wed - Sun, Oct 26 to Oct 30, 8:00am - 5:00pm


Harvard Medical School, Joseph B. Martin Conference Center, 77 Avenue Louis Pasteur, Boston, MA

BMP 2016 is designed to expand our understanding of how the BMP signaling axis (BMP/TGFβ/Activin/GDF) influences development and maintenance of organ systems and seeks to uncover how dysregulation of this control results in disease. We challenge attendees to focus on the interconnected nature of the branches of BMP signaling axis, something that is now being considered for the first time and has tremendous implications for understanding diseases of BMP signaling.